Persistence of Nondysplastic Barrett's Esophagus Is Not Protective Against Progression to Adenocarcinoma

Clin Gastroenterol Hepatol. 2017 Jun;15(6):950-952. doi: 10.1016/j.cgh.2017.02.019. Epub 2017 Feb 24.

Affiliations

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
² Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
³ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: iyer.prasad@mayo.edu.

PMID: 28238955
DOI: 10.1016/j.cgh.2017.02.019

No abstract available

Publication types

Letter

MeSH terms

Adenocarcinoma / etiology*
Adenocarcinoma / pathology
Aged
Barrett Esophagus / complications
Barrett Esophagus / pathology*
Cohort Studies
Disease Progression
Esophageal Neoplasms / etiology*
Esophageal Neoplasms / pathology
Female
Humans
Male
Middle Aged
Proportional Hazards Models
Time Factors